Harbor Investment Advisory’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.8K Buy
+486
New +$58.8K ﹤0.01% 751
2023
Q3
– Sell
-2,745
Closed -$57.9K – 1261
2023
Q2
$57.9K Buy
2,745
+263
+11% +$4.99K 0.01% 670
2023
Q1
$42.3K Hold
2,482
– – 0.01% 753
2022
Q4
$49.6K Hold
2,482
– – 0.01% 694
2022
Q3
$53K Buy
2,482
+432
+21% +$10.4K 0.01% 675
2022
Q2
$40K Hold
2,050
– – 0.01% 763
2022
Q1
$48K Hold
2,050
– – 0.01% 765
2021
Q4
$56K Hold
2,050
– – 0.01% 707
2021
Q3
$56K Hold
2,050
– – 0.01% 709
2021
Q2
$58K Buy
+2,050
New +$60.8K 0.01% 667

Other funds holding INSM

Harbor Investment Advisory's INSM Position: Q2 2026 in Review

Harbor Investment Advisory opened a new position in Insmed (INSM) in Q2 2026: 486 shares worth $51.8K. The stake represents ﹤0.01% of the portfolio and ranks #751 among its holdings. This is a return to the name: Harbor Investment Advisory previously reported a position in INSM as recently as Q2 2023.

Harbor Investment Advisory first reported a position in INSM in Q2 2021 and has held it in 10 quarters since. The position peaked at $58K in Q2 2021. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Harbor Investment Advisory held 486 shares of Insmed worth $51.8K as of Q2 2026.
  • Insmed was a new Harbor Investment Advisory position in Q2 2026.
  • Insmed made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #751 holding.
  • Harbor Investment Advisory first reported a position in Insmed in Q2 2021 and has held it in 10 quarters since.
  • Harbor Investment Advisory's Insmed position peaked at $58K in Q2 2021.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.